| Name |
|---|
HCHGQ1 GeneHematocrit/hemoglobin quantitative trait locus 1 |
HCHGQ3 GeneHematocrit/hemoglobin quantitative trait locus 3 |
HCHGQ2 GeneHematocrit/hemoglobin quantitative trait locus 2 |
HPFH2 Genehereditary persistence of fetal hemoglobin, heterocellular, Indian type |
HBE1 Genehemoglobin, epsilon 1 The epsilon globin gene (HBE) is normally expressed in the embryonic yolk sac: two epsilon chains together with two zeta chains (an alpha-like globin) constitute the embryonic hemoglobin Hb Gower I; two epsilon chains together with two alpha chains form the embryonic Hb Gower II. Both of these embryonic hemoglobins are normally supplanted by fetal, and later, adult hemoglobin. The five beta-like globin genes are found within a 45 kb cluster on chromosome 11 in the following order: 5'-epsilon - G-gamma - A-gamma - delta - beta-3' [provided by RefSeq, Jul 2008] |
HBBP1 Genehemoglobin, beta pseudogene 1 |
AHSP Genealpha hemoglobin stabilizing protein This gene encodes a molecular chaperone which binds specifically to free alpha-globin and is involved in hemoglobin assembly. The encoded protein binds to monomeric alpha-globin until it has been transferred to beta-globin to form a heterodimer, which in turn binds to another heterodimer to form the stable tetrameric hemoglobin. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015] |
HBM Genehemoglobin, mu The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. This gene has an ORF encoding a 141 aa polypeptide which is similar to the delta globins found in reptiles and birds. This locus was originally described as a pseudogene; however, it is currently thought to be a protein-coding gene. [provided by RefSeq, Jul 2008] |
HBD Genehemoglobin, delta The delta (HBD) and beta (HBB) genes are normally expressed in the adult: two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin. Two alpha chains plus two delta chains constitute HbA-2, which with HbF comprises the remaining 3% of adult hemoglobin. Five beta-like globin genes are found within a 45 kb cluster on chromosome 11 in the following order: 5'-epsilon--Ggamma--Agamma--delta--beta-3'. Mutations in the delta-globin gene are associated with beta-thalassemia. [provided by RefSeq, Jul 2008] |
HBB Genehemoglobin, beta The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008] |
HBZ Genehemoglobin, zeta Zeta-globin is an alpha-like hemoglobin. The zeta-globin polypeptide is synthesized in the yolk sac of the early embryo, while alpha-globin is produced throughout fetal and adult life. The zeta-globin gene is a member of the human alpha-globin gene cluster that includes five functional genes and two pseudogenes. The order of genes is: 5' - zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 -alpha-1 - theta1 - 3'. [provided by RefSeq, Nov 2009] |
HBZP1 Genehemoglobin, zeta pseudogene 1 |
HBA1 Genehemoglobin, alpha 1 The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008] |
HBAP1 Genehemoglobin, alpha pseudogene 1 |
HBFQTL4 GeneFetal hemoglobin QTL on chromosome 8 |
HBFQTL2 Genehereditary persistence of fetal hemoglobin, heterocellular |
HBA2 Genehemoglobin, alpha 2 The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008] |
HBQ1 Genehemoglobin, theta 1 Theta-globin mRNA is found in human fetal erythroid tissue but not in adult erythroid or other nonerythroid tissue. The theta-1 gene may be expressed very early in embryonic life, perhaps sometime before 5 weeks. Theta-1 is a member of the human alpha-globin gene cluster that involves five functional genes and two pseudogenes. The order of genes is: 5' - zeta - pseudozeta - mu - pseudoalpha-2 -pseudoalpha-1 - alpha-2 - alpha-1 - theta-1 - 3'. Research supports a transcriptionally active role for the gene and a functional role for the peptide in specific cells, possibly those of early erythroid tissue. [provided by RefSeq, Jul 2008] |
HBG2 Genehemoglobin, gamma G The gamma globin genes (HBG1 and HBG2) are normally expressed in the fetal liver, spleen and bone marrow. Two gamma chains together with two alpha chains constitute fetal hemoglobin (HbF) which is normally replaced by adult hemoglobin (HbA) at birth. In some beta-thalassemias and related conditions, gamma chain production continues into adulthood. The two types of gamma chains differ at residue 136 where glycine is found in the G-gamma product (HBG2) and alanine is found in the A-gamma product (HBG1). The former is predominant at birth. The order of the genes in the beta-globin cluster is: 5'- epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008] |
HBG1 Genehemoglobin, gamma A The gamma globin genes (HBG1 and HBG2) are normally expressed in the fetal liver, spleen and bone marrow. Two gamma chains together with two alpha chains constitute fetal hemoglobin (HbF) which is normally replaced by adult hemoglobin (HbA) at birth. In some beta-thalassemias and related conditions, gamma chain production continues into adulthood. The two types of gamma chains differ at residue 136 where glycine is found in the G-gamma product (HBG2) and alanine is found in the A-gamma product (HBG1). The former is predominant at birth. The order of the genes in the beta-globin cluster is: 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008] |
RDPA Generefsum disease, adult, with increased pipecolicacidemia |
NPC2 GeneNiemann-Pick disease, type C2 This gene encodes a protein containing a lipid recognition domain. The encoded protein may function in regulating the transport of cholesterol through the late endosomal/lysosomal system. Mutations in this gene have been associated with Niemann-Pick disease, type C2 and frontal lobe atrophy. [provided by RefSeq, Jul 2008] |
NPC1 GeneNiemann-Pick disease, type C1 This gene encodes a large protein that resides in the limiting membrane of endosomes and lysosomes and mediates intracellular cholesterol trafficking via binding of cholesterol to its N-terminal domain. It is predicted to have a cytoplasmic C-terminus, 13 transmembrane domains, and 3 large loops in the lumen of the endosome - the last loop being at the N-terminus. This protein transports low-density lipoproteins to late endosomal/lysosomal compartments where they are hydrolized and released as free cholesterol. Defects in this gene cause Niemann-Pick type C disease, a rare autosomal recessive neurodegenerative disorder characterized by over accumulation of cholesterol and glycosphingolipids in late endosomal/lysosomal compartments.[provided by RefSeq, Aug 2009] |
CMT2H GeneCharcot-Marie-Tooth disease, axonal, type 2H |
CMT2G GeneCharcot-Marie-Tooth disease, axonal, type 2G |
GRD2 GeneGraves disease, susceptibility to, 2 |
GRD1 GeneGraves disease, susceptiblity to, 1 |
GRDX GeneGraves disease, susceptibility to, X-linked |
COPD14 GeneChronic obstructive pulmonary disease QTL 14 |
PDDC1 GeneParkinson disease 7 domain containing 1 Predicted to enable glyoxalase III activity. Predicted to be involved in methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione. Located in extracellular exosome. [provided by Alliance of Genome Resources, Mar 2025] |
CELIAC8 GeneCeliac disease, susceptibility to, 8 |
CELIAC2 Geneceliac disease 2 |
CELIAC5 GeneCeliac disease, susceptibility to, 5 |
CELIAC6 GeneCeliac disease, susceptibility to, 6 |
CELIAC7 GeneCeliac disease, susceptibility to, 7 |
AIS4 Geneautoimmune disease, susceptibility to, 4 |
COPD3 GeneChronic obstructive pulmonary disease QTL 3 |
COPD2 GeneChronic obstructive pulmonary disease QTL 2 |
COPD1 GeneChronic obstructive pulmonary disease QTL 1 |
COPD6 GeneChronic obstructive pulmonary disease QTL 6 |
COPD5 GeneChronic obstructive pulmonary disease QTL 5 |
COPD4 GeneChronic obstructive pulmonary disease QTL 4 |
COPD8 GeneChronic obstructive pulmonary disease QTL 8 |
PKHD1L1 Genepolycystic kidney and hepatic disease 1 (autosomal recessive)-like 1 Predicted to enable signaling receptor activity. Predicted to be involved in immune response. Predicted to act upstream of or within sensory perception of sound. Predicted to be located in cytosol; extracellular space; and membrane. Implicated in autosomal recessive nonsyndromic deafness. [provided by Alliance of Genome Resources, Mar 2025] |
BED GeneBornholm eye disease |
PKD1P1 Genepolycystic kidney disease 1 (autosomal dominant) pseudogene 1 |
PKD1P2 Genepolycystic kidney disease 1 (autosomal dominant) pseudogene 2 |
PKD1P3 Genepolycystic kidney disease 1 (autosomal dominant) pseudogene 3 |
PKD1P4 Genepolycystic kidney disease 1 (autosomal dominant) pseudogene 4 |
PKD1P5 Genepolycystic kidney disease 1 (autosomal dominant) pseudogene 5 |
PKD1P6 Genepolycystic kidney disease 1 (autosomal dominant) pseudogene 6 |
PKD3 Genepolycystic kidney disease 3 (autosomal dominant) |
PKD2 Genepolycystic kidney disease 2 (autosomal dominant) This gene encodes a member of the polycystin protein family. The encoded protein is a multi-pass membrane protein that functions as a calcium permeable cation channel, and is involved in calcium transport and calcium signaling in renal epithelial cells. This protein interacts with polycystin 1, and they may be partners in a common signaling cascade involved in tubular morphogenesis. Mutations in this gene are associated with autosomal dominant polycystic kidney disease type 2. [provided by RefSeq, Mar 2011] |
PKD1 Genepolycystic kidney disease 1 (autosomal dominant) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008] |
OED GeneOregon eye disease |
CHDS4 GeneCoronary heart disease, susceptibility to, 4 |
GBD3 Genegallbladder disease 3 |
CMTDIA GeneCharcot-Marie-Tooth disease, dominant intermediate 2 |
PDB6 GenePaget disease of bone 6 |
PDB4 GenePaget disease of bone 4 |
PDB5 GenePaget disease of bone 5 |
PDB1 GenePaget disease of bone 1 |
IBD9 Geneinflammatory bowel disease 9 |
IBD8 Geneinflammatory bowel disease 8 |
IBD3 Geneinflammatory bowel disease 3 |
IBD2 Geneinflammatory bowel disease 2 |
IBD5 Geneinflammatory bowel disease 5 |
IBD4 Geneinflammatory bowel disease 4 |
IBD7 Geneinflammatory bowel disease 7 |
IBD6 Geneinflammatory bowel disease 6 |
COPD17 GeneChronic obstructive pulmonary disease QTL 17 |
GBD2 Genegallbladder disease 2 |
PAOD1 GenePeripheral arterial occlusive disease 1 |
COPD7 GeneChronic obstructive pulmonary disease QTL 7 |
COPD9 GeneChronic obstructive pulmonary disease QTL 9 |
DDD3 GeneDowling-Degos disease 3 |
NAFLD2 GeneFatty liver disease, nonalcoholic, susceptibility to, 2 |
NAFLD1 GeneFatty liver disease 1, susceptiblity to |
EPM2A Geneepilepsy, progressive myoclonus type 2A, Lafora disease (laforin) This gene encodes a dual-specificity phosphatase and may be involved in the regulation of glycogen metabolism. The protein acts on complex carbohydrates to prevent glycogen hyperphosphorylation, thus avoiding the formation of insoluble aggregates. Loss-of-function mutations in this gene have been associated with Lafora disease, a rare, adult-onset recessive neurodegenerative disease, which results in myoclonus epilepsy and usually results in death several years after the onset of symptoms. The disease is characterized by the accumulation of insoluble particles called Lafora bodies, which are derived from glycogen. [provided by RefSeq, Jan 2018] |
PKDTS Genepolycystic kidney disease, infantile severe, with tuberous sclerosis |
AITD2 GeneAutoimmune thyroid disease, susceptibility to, 2 |
AITD1 GeneAutoimmune thyroid disease, susceptibility to, 1 |
AITD4 GeneAutoimmune thyroid disease, susceptibility to, 4 |
KWE Genekeratolytic winter erythema (Oudtshoorn skin disease) |
LOC613206 Genemyeloproliferative disease associated tumor antigen 5 |
RMD1 Generippling muscle disease 1 |
AD10 GeneAlzheimer disease-10 |
AD11 GeneAlzheimer disease-11 |
AD12 GeneAlzheimer disease 12 |
AD13 GeneAlzheimer disease-13 |
AD14 GeneAlzheimer disease 14 |
AD16 GeneAlzheimer disease 16 |
AD17 GeneAlzheimer disease 17 |
PKD1L1 Genepolycystic kidney disease 1 like 1 This gene encodes a member of the polycystin protein family containing 11 transmembrane domains, a receptor for egg jelly (REJ) domain, and a polycystin-1, lipoxygenase, alpha-toxin (PLAT) domain. The encoded protein may play a role in the male reproductive system. Alternative splice variants have been described but their biological nature has not been determined. [provided by RefSeq, Jul 2008] |
PKD1L2 Genepolycystic kidney disease 1-like 2 (gene/pseudogene) This gene encodes a member of the polycystin protein family. This protein may function as a G-protein-coupled component or regulator of cation channel pores. The long isoform of this protein contains 11 transmembrane domains, a latrophilin/CL-1-like GPCR proteolytic site (GPS) domain, and a polycystin-1, lipoxygenase, alpha-toxin (PLAT) domain. Alternative splicing results in multiple transcript variants encoding distinct isoforms. This gene is a polymorphic pseudogene in humans. [provided by RefSeq, May 2022] |
PKD1L3 Genepolycystic kidney disease 1-like 3 This gene encodes a member of the polycystin protein family. The encoded protein contains 11 transmembrane domains, a latrophilin/CL-1-like GPCR proteolytic site (GPS) domain, and a polycystin-1, lipoxygenase, alpha-toxin (PLAT) domain. This protein may function as a component of cation channel pores.[provided by RefSeq, Apr 2009] |
HDPA GeneHodgkin disease, susceptibility, pseudoautosomal |
AD6 GeneAlzheimer disease 6 |
AD7 GeneAlzheimer disease 7 |
AD5 GeneAlzheimer disease 5 |
AD8 GeneAlzheimer disease 8 |
AD9 GeneAlzheimer disease 9 |
PARK16 GeneParkinson disease 16 (susceptibility) |
PARK10 GeneParkinson disease 10 (susceptibility) |
PARK12 GeneParkinson disease 12 (susceptibility) |
HSCR9 GeneHirschsprung disease, susceptibility to, 9 |
HSCR8 GeneHirschsprung disease modifier 2 |
HSCR5 GeneHirschsprung disease, susceptibility to, 5 The disorder described by Hirschsprung (1888) and known as Hirschsprung disease or aganglionic megacolon is characterized by congenital absence of intrinsic ganglion cells in the myenteric (Auerbach) and submucosal (Meissner) plexuses of the gastrointestinal tract. Patients are diagnosed with the short-segment form (S-HSCR, approximately 80% of cases) when the aganglionic segment does not extend beyond the upper sigmoid, and with the long-segment form (L-HSCR) when aganglionosis extends proximal to the sigmoid. Total colonic aganglionosis and total intestinal HSCR also occur (Amiel et al., 2008 [PubMed 17965226]). Isolated HSCR appears to be of complex nonmendelian inheritance with low sex-dependent penetrance and variable expression according to the length of the aganglionic segment, suggestive of the involvement of one or more genes with low penetrance (Amiel et al., 2008 [PubMed 17965226]). For a general description and a discussion of genetic heterogeneity of Hirschsprung disease (HSCR), see MIM 142623.[supplied by OMIM, Feb 2011] |
HSCR7 GeneHirschsprung disease, short-segment, 3 |
HSCR6 GeneHirschsprung disease, short-segment, 2 |
IBD27 GeneInflammatory bowel disease-27 |
IBD20 GeneInflammatory bowel disease-20 |
IBD21 GeneInflammatory bowel disease-21 |
IBD22 GeneInflammatory bowel disease-22 |
IBD23 GeneInflammatory bowel disease-23 |
IBD24 GeneInflammatory bowel disease-24 |
IBD25 GeneInflammatory bowel disease-25 |
IBD26 GeneInflammatory bowel disease-26 |
CCAL1 Genechondrocalcinosis 1 (calcium pyrophosphate-deposition disease, early onset osteoarthritis) |
PARK3 GeneParkinson disease 3 (autosomal dominant, Lewy body) |
CELIAC9 GeneCeliac disease, susceptibility to, 9 |
CTD GeneCoats disease |
AD15 GeneAlzheimer disease-15 |
COPD13 GeneChronic obstructive pulmonary disease QTL 13 |
COPD12 GeneChronic obstructive pulmonary disease QTL 12 |
COPD11 GeneChronic obstructive pulmonary disease QTL 11 |
COPD10 GeneChronic obstructive pulmonary disease QTL 10 |
COPD16 GeneChronic obstructive pulmonary disease QTL 16 |
COPD15 GeneChronic obstructive pulmonary disease QTL 15 |
COPD19 GeneChronic obstructive pulmonary disease QTL 19 |
COPD18 GeneChronic obstructive pulmonary disease QTL 18 |
MYMY1 Genemoyamoya disease 1 |
MYMY3 Genemoyamoya disease 3 |
MYMY4 GeneMoyamoya disease 4 |
COPD GenePulmonary disease, chronic obstructive, severe early-onset |
CHDS3 GeneCoronary heart disease, susceptibility to, 3 |
CHDS2 GeneCoronary heart disease, susceptibility to, 2 |
CHDS1 GeneCoronary heart disease, susceptibility to, 1 |
CHDS9 GeneCoronary heart disease, suscpetibility to, 9 |
CHDS8 GeneCoronary heart disease, susceptibility to, 8 |
IBD11 GeneInflammatory bowel disease 11 |
IBD12 GeneInflammatory bowel disease 12 |
IBD15 GeneInflammatory bowel disease-15 |
IBD16 GeneInflammatory bowel disease-16 |
IBD19 GeneInflammatory bowel disease 19 |
IBD18 GeneInflammatory bowel disease-18 |
NDP GeneNorrie disease (pseudoglioma) This gene encodes a secreted protein with a cystein-knot motif that activates the Wnt/beta-catenin pathway. The protein forms disulfide-linked oligomers in the extracellular matrix. Mutations in this gene result in Norrie disease and X-linked exudative vitreoretinopathy. [provided by RefSeq, Feb 2009] |
PKHD1 Genepolycystic kidney and hepatic disease 1 (autosomal recessive) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008] |
PKD2L2 Genepolycystic kidney disease 2-like 2 Predicted to enable calcium channel activity. Predicted to be involved in detection of mechanical stimulus. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Mar 2025] |
PKD2L1 Genepolycystic kidney disease 2-like 1 This gene encodes a member of the polycystin protein family. The encoded protein contains multiple transmembrane domains, and cytoplasmic N- and C-termini. The protein may be an integral membrane protein involved in cell-cell/matrix interactions. This protein functions as a calcium-regulated nonselective cation channel. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011] |
COPD28 GeneChronic obstructive pulmonary disease QTL 28 |
COPD29 GeneChronic obstructive pulmonary disease QTL 29 |
COPD22 GeneChronic obstructive pulmonary disease QTL 22 |
COPD23 GeneChronic obstructive pulmonary disease QTL 23 |
COPD20 GeneChronic obstructive pulmonary disease QTL 20 |
COPD21 GeneChronic obstructive pulmonary disease QTL 21 |
COPD26 GeneChronic obstructive pulmonary disease QTL 26 |
COPD27 GeneChronic obstructive pulmonary disease QTL 27 |
COPD24 GeneChronic obstructive pulmonary disease QTL 24 |
COPD25 GeneChronic obstructive pulmonary disease QTL 25 |
CELIAC12 GeneCeliac disease, susceptibility to, 12 |
CELIAC13 GeneCeliac disease, susceptibility to, 13 |
CELIAC10 GeneCeliac disease, susceptibility to, 10 |
CELIAC11 GeneCeliac disease, susceptibility to, 11 |